← Back
Data updated: Mar 10, 2026
CARDINAL HEALTH 414
Oncology
CARDINAL HEALTH 414 is a specialty pharmaceutical company focused on Oncology. Key products include LYMPHOSEEK KIT.
1981
Since
5
Drugs
-
Trials
2
Approved (2yr)
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
0 drugs Phase 2: 3
Pipeline Strength Pro
Loading...
Active (5)
Discontinued (0)
Company Info
- First Approval
- 1981-02-17
- Latest
- 2025-05-22
- Applications
- 5